2019-nCoV Ikhithi yoVavanyo lwe-Antibody engathathi hlangothi (indlela yegolide ye-colloidal)
Intshayelelo
Iprotein ye-spike ichongiwe njengento ekujoliswe kuyo ye-antigenic kuphuhliso lwesitofu sokugonya ngokuchasene ne-2019-nCoV, kwaye i-RBD yeprotheni ye-S yeyona nto iphambili.
Bangaphezulu kwe-180 abagqatswa bogonyo, ngokusekwe kumaqonga ahlukeneyo ahlukeneyo asaphuhlayo ngokuchasene ne-2019-nCoV.
Iprotheyini ye-S yeyona nto iphambili ekujoliswe kuyo kwi-neutralizing antibodies;
Uninzi lwezi zithinteli-zifo zijolisa kwi-RBD ye-S protein.
Ukugweba njani ukusebenza kogonyo luka-2019-nCoV?--- Uvavanyo lwe-Antibody olungathathi hlangothi
Iingenelo
Uvavanyo lwesitofu sangaphambili
Ngaphambi kokugonywa, abaviwa banokufumanisa i-antibody engathathi hlangothi ye-RBD ukufumanisa ukuba ugonyo luyimfuneko;
Uninzi lwamachiza lugqunyiwe
Iyakwazi ukubona izithinteli-zifo ezizizo eziveliswa luninzi lwamayeza okugonya emarikeni;
Ukukhawuleza kwaye kulula
Umsebenzi ulula, akukho sixhobo sokukhangela esifunekayo, iziphumo zingafumaneka kwimizuzu eyi-15.
Umsebenzi wokuchonga
Inokwahlula i-antibody engathathi hlangothi ka-2019-nCoV eveliswe sisitofu sokugonya sika-2019-nCoV okanye i-antibody eveliswe lusulelo lwe-2019-nCoV kuhlobo oluthile logonyo, olufana nogonyo lweViral (engaphindaphindiyo), isitofu sokugonya se-RNA kunye nogonyo lweprotheyini. ;
Uvavanyo lwegazi lonke
Uvavanyo lwegazi lonke lwenza utyando lube lula ngakumbi.
Amacandelo
| Amacandelo | Izithako eziphambili | Ilayisha ubungakanani (Inkcazo) | |
| 1 T/Kit | 5 T/Kit | ||
| Ikhadi lovavanyo | Umtya wovavanyo oqulathe i-colloidal yegolide ebhalwe anti-human IgG antibody, igolide ye-colloidal ebhalwe anti-inkukhu IgY antibody, 2019-nCoV S-RBD recombinant protein, 2019-nCoV recombinant N protein, Chicken IgY antibody | 1 pc | iipcs ezi-5 |
| Isampulu yokuxutywa | I-0.01M isisombululo se-Phosphate buffer, 0.5% Tween-20 | 0.5mL | 2.5mL |
Ukusebenza
| Hecin reagent | Uvavanyo lweklinikhi lwe-serum virus neutralization | Iyonke | |
| Okuhle | Ibi | ||
| Okuhle | 84 | 17 | 101 |
| Ibi | 8 | 190 | 198 |
| Iyonke | 92 | 207 | 299 |
| Uvakalelo lweklinikhi | 84/92 91.30% (95%CI: 83.58%～96.17%) | ||
| Ukucaciswa kweklinikhi | 190/207 91.79% (95%CI: 87.18%～95.14%) | ||
| Ukuchaneka | 274/299 91.64% (95%CI: 87.90%～94.52%) | ||
I-Hecin reagent Ukusebenza ngokuchasene neNdlela yoMthelekisi kwi-serum / isampuli zeplasma.
| Hecin reagent | Uvavanyo lweklinikhi lwe-serum virus neutralization | Iyonke | |
| Okuhle | Ibi | ||
| Okuhle | 84 | 16 | 100 |
| Ibi | 8 | 191 | 199 |
| Iyonke | 92 | 207 | 299 |
| Uvakalelo lweklinikhi | 84/92 91.30% (95%CI: 83.58%～96.17%) | ||
| Ukucaciswa kweklinikhi | 191/207 92.27% (95%CI: 87.75%～95.52%) | ||
| Ukuchaneka | 275/299 91.97% (95%CI: 88.29%～94.79%) | ||
IHecin reagent Ukusebenza ngokuchasene neNdlela yoMthelekisi kwiisampulu zegazi elipheleleyo.
Ubungakanani besicelo
Ugonyo lwangaphambili
Qinisekisa ukuba bosulelwe yi-coronavirus entsha nokuba basafuna ukugonywa na;
Ixesha lokugonywa
Ukumisela ukuba ingaba i-antibody entsha engasebenziyo iye yaveliswa;
Inqanaba lamva lokutofa
Ngokwendawo yobhubhane ka-2019-nCoV, kucetyiswa ukuba kubonwe ubukho be-2019-nCoV engathathi hlangothi rhoqo kwiinyanga ezintathu.
Thelekisa ne-2019-nCoV S-RBD Neutralizing Antibody Test Kit (Indlela yeGolide yeColloidal)
Fumana i-S-RBD IgG, i-N protein ye-IgG iziphumo zovavanyo ngexesha elifanayo, uhlalutyo olubanzi lweziphumo zovavanyo.
*Udinga uvavanyo olongezelelweyo: Kuyacetyiswa ukuba uphinde uvavanye okanye uvavanye nezinye iimveliso zendlela yoxinaniso oluchanekileyo.
Inkqubo yoVavanyo
Isatifikethi soBhaliso
Ukuchazwa kwemveliso
Hecin JT09-Umfanekiso weMveliso
Hecin JT09-50PCS Umfanekiso weMveliso
I-JT09- 50T
